Events & Webinars
-
Webinar: A Drug Repurposing Approach for Clinical Treatment of Triple-Negative Breast Cancer
Learn about a novel, potential treatment for Triple-Negative Breast Cancer (TNBC). William Reinhold and his team at the NCI repurposed two separate therapeutic compounds ─ acetalax and bisacodyl ─ into novel treatments for TNBC.